MY157827A - Sulfonamide substituted imidazoquinolines - Google Patents

Sulfonamide substituted imidazoquinolines

Info

Publication number
MY157827A
MY157827A MYPI20042461A MYPI20042461A MY157827A MY 157827 A MY157827 A MY 157827A MY PI20042461 A MYPI20042461 A MY PI20042461A MY PI20042461 A MYPI20042461 A MY PI20042461A MY 157827 A MY157827 A MY 157827A
Authority
MY
Malaysia
Prior art keywords
sulfonamide substituted
useful
substituted imidazoquinolines
compounds
imidazoquinolines
Prior art date
Application number
MYPI20042461A
Inventor
George Walter Griesgraber
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US48320003P priority Critical
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Publication of MY157827A publication Critical patent/MY157827A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Abstract

IMIDAZOQUINOLINE AND TETRAHYDROIMIDAZOQUINOLINE COMPOUNDS THAT CONTAIN SULFONAMIDE FUNCTIONALITY AT THE 1-POSITION ARE USEFUL AS IMMUNE RESPONSE MODIFIERS. THE COMPOUNDS AND COMPOSITIONS OF THE INVENTION CAN INDUCE THE BIOSYNTHESIS OF VARIOUS CYTOKINES AND ARE USEFUL IN THE TREATMENT OF A VARIETY OF CONDITIONS INCLUDING VIRAL DISEASES AND NEOPLASTIC DISEASES.
MYPI20042461A 2003-06-27 2004-06-24 Sulfonamide substituted imidazoquinolines MY157827A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US48320003P true 2003-06-27 2003-06-27

Publications (1)

Publication Number Publication Date
MY157827A true MY157827A (en) 2016-07-29

Family

ID=33563911

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20042461A MY157827A (en) 2003-06-27 2004-06-24 Sulfonamide substituted imidazoquinolines

Country Status (16)

Country Link
EP (1) EP1638566A4 (en)
JP (1) JP2007521280A (en)
KR (1) KR20060035637A (en)
CN (1) CN1812789B (en)
AR (2) AR044922A1 (en)
AU (1) AU2004253929A1 (en)
BR (1) BRPI0411916A (en)
CA (1) CA2529322A1 (en)
IL (1) IL172427D0 (en)
MX (1) MXPA06000144A (en)
MY (1) MY157827A (en)
NZ (1) NZ544330A (en)
RU (1) RU2374246C2 (en)
TW (2) TW200514784A (en)
WO (2) WO2005003065A2 (en)
ZA (1) ZA200600769B (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265351A1 (en) 2003-04-10 2004-12-30 Miller Richard L. Methods and compositions for enhancing immune response
AU2004266641A1 (en) 2003-08-12 2005-03-03 3M Innovative Properties Company Oxime substituted imidazo-containing compounds
RU2006105101A (en) 2003-08-27 2007-10-10 3М Инновейтив Пропертиз Компани (US) Aryloxy and substituted arilalkilenoksi imidazoquinolines
CA2537763A1 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for cd5+ b cell lymphoma
CA2540598C (en) 2003-10-03 2013-09-24 3M Innovative Properties Company Pyrazolopyridines and analogs thereof
NZ546273A (en) 2003-10-03 2009-05-31 Coley Pharm Group Inc Alkoxy substituted imidazoquinolines
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
CA2545825A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Hydroxylamine substituted imidazo ring compounds
US7897767B2 (en) 2003-11-14 2011-03-01 3M Innovative Properties Company Oxime substituted imidazoquinolines
MXPA06005910A (en) 2003-11-25 2006-08-23 3M Innovative Properties Co Substituted imidazo ring systems and methods.
US8940755B2 (en) * 2003-12-02 2015-01-27 3M Innovative Properties Company Therapeutic combinations and methods including IRM compounds
WO2005066170A1 (en) 2003-12-29 2005-07-21 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
US8735421B2 (en) 2003-12-30 2014-05-27 3M Innovative Properties Company Imidazoquinolinyl sulfonamides
CA2559863A1 (en) 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US8017779B2 (en) 2004-06-15 2011-09-13 3M Innovative Properties Company Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US7897609B2 (en) 2004-06-18 2011-03-01 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
US8026366B2 (en) 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
US7915281B2 (en) 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
US8541438B2 (en) 2004-06-18 2013-09-24 3M Innovative Properties Company Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
EP1831221B1 (en) 2004-12-30 2012-08-08 3M Innovative Properties Company Substituted chiral fused 1,2 imidazo 4,5-c ring compounds
CA2592904C (en) 2004-12-30 2015-04-07 3M Innovative Properties Company Chiral fused [1,2]imidazo[4,5-c] ring compounds
CN101443005A (en) * 2004-12-30 2009-05-27 科勒制药集团公司 Immune response modifier formulations and methods
JP2008530022A (en) 2005-02-04 2008-08-07 コーリー ファーマシューティカル グループ,インコーポレイテッド Aqueous gel formulations containing immune response modifier
JP5122980B2 (en) 2005-02-09 2013-01-16 スリーエム イノベイティブ プロパティズ カンパニー Alkyloxy-substituted thiazoloquinolines and alkyloxy-substituted thiazolonaphthylidenes
JP2008530113A (en) 2005-02-11 2008-08-07 コーリー ファーマシューティカル グループ,インコーポレイテッド Oxime and hydroxylamine-substituted imidazo [4,5-c] ring compounds and methods
US7943636B2 (en) 2005-04-01 2011-05-17 3M Innovative Properties Company 1-substituted pyrazolo (3,4-C) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
CA2602683A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
EP1922317A4 (en) * 2005-09-09 2009-04-15 Coley Pharm Group Inc Amide and carbamate derivatives of n-{2-ý4-amino-2- (ethoxymethyl)-1h-imidazoý4,5-c¨quinolin-1-yl¨-1,1-dimethylethyl}methanesulfonamide and methods
ZA200803029B (en) * 2005-09-09 2009-02-25 Coley Pharm Group Inc Amide and carbamate derivatives of alkyl substituted /V-[4-(4-amino-1H-imidazo[4,5-c] quinolin-1-yl)butyl] methane-sulfonamides and methods
BRPI0616338A2 (en) * 2005-09-23 2011-06-14 Coley Pharm Group Inc Method for 1h-imidazo [4,5-c] pyridines and analogs thereof
WO2008008432A2 (en) 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
ES2436540T3 (en) 2008-03-24 2014-01-02 4Sc Discovery Gmbh New substituted imidazoquinolines
ES2617451T3 (en) 2010-08-17 2017-06-19 3M Innovative Properties Company Lipidated compositions of immune response modifying compounds, formulations, and methods
EP2718292B1 (en) 2011-06-03 2018-03-14 3M Innovative Properties Company Hydrazino 1h-imidazoquinolin-4-amines and conjugates made therefrom
CN103582496B (en) 2011-06-03 2016-05-11 3M创新有限公司 Having a polyethylene glycol segment and a heterobifunctional linker conjugate prepared therefrom immune response modifier
US9695171B2 (en) 2013-12-17 2017-07-04 Pfizer Inc. 3,4-disubstituted-1 H-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7H-pyrrolo[2,3-c]pyridazines as LRRK2 inhibitors
EP3350178A1 (en) 2015-09-14 2018-07-25 Pfizer Inc Novel imidazo [4,5-c]quinoline and imidazo [4,5-c][1,5]naphthyridine derivatives as lrrk2 inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331539B1 (en) * 1999-06-10 2001-12-18 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines
DK1719511T3 (en) * 2001-11-16 2009-04-14 Coley Pharm Group Inc N- [4- (4-amino-2-ethyl-1H-imidazo [4,5-c] quinolin-1-yl) butyl] methanesulfonamide, a pharmaceutical composition comprising the same, and use thereof
US6677349B1 (en) * 2001-12-21 2004-01-13 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines

Also Published As

Publication number Publication date
AR044923A1 (en) 2005-10-12
AR044922A1 (en) 2005-10-12
BRPI0411916A (en) 2006-08-15
AU2004253929A1 (en) 2005-01-13
CN1812789B (en) 2010-07-14
NZ544330A (en) 2009-06-26
WO2005003064A3 (en) 2005-03-31
KR20060035637A (en) 2006-04-26
WO2005003065A2 (en) 2005-01-13
WO2005003065A3 (en) 2005-03-10
TW200514784A (en) 2005-05-01
EP1638566A4 (en) 2009-03-25
CN1812789A (en) 2006-08-02
RU2374246C2 (en) 2009-11-27
IL172427D0 (en) 2006-04-10
JP2007521280A (en) 2007-08-02
RU2005138915A (en) 2006-06-27
EP1638566A2 (en) 2006-03-29
ZA200600769B (en) 2007-05-30
TW200511992A (en) 2005-04-01
MXPA06000144A (en) 2006-04-07
WO2005003064A2 (en) 2005-01-13
CA2529322A1 (en) 2005-01-13

Similar Documents

Publication Publication Date Title
DK1537878T3 (en) Immune potentiating compositions
DE60237087D1 (en) Pharmaceutical compositions for the coordinated delivery of nsaid
DK1564210T3 (en) 4-Oxoquinoline Compounds and Their Use as HIV Integrase Inhibitors
DK1644021T3 (en) Methods and compositions for the treatment of gastrointestinal diseases
EP1551372B8 (en) Sequestering subunit and related compositions and methods
GB2389530B (en) Pharmaceutical compositions
DK1515702T3 (en) Abuse-safe form of administration
DE60227068D1 (en) Therapeutic processes using vegetable compositions
DK2128246T3 (en) Methods and compositions for the preparation of orthogonal tRNA-aminoacyl-tRNA synthetase pairs.
DE60239648D1 (en) Pharmaceutical compositions for the treatment of asthma
PT1605956E (en) Administration of capsaicinoids for the treatment of osteoarthritis
ZA200401004B (en) Combination for the treatment of inflammatory disorders
AU2002313828A1 (en) Pharmaceutical compositions for the treatment of asthma
GEP20063741B (en) Nonaryl-Heterocyclic NMDA/NR2B Antagonists
SG149063A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
EP1567230A4 (en) Compositions for removing stains from dental surfaces, and methods of making and using the same
TW200524939A (en) Compositions useful as inhibitors of protein kinases
ZA200502220B (en) Oral formulations
AU2003224725A8 (en) Hiv therapeutic
HK1069981A1 (en) Oral compositions
IL157741A (en) Pharmaceutical compositions
IL177772D0 (en) Methods and compositions for the treatment of gastrointestinal disorders
YU30004A (en) Use of flibanserin in the treatment of sexual disorders
IL166457A (en) Quinoline derivatives , compositions comprising them, their use for the manufacture of the compositions and process for the manufacture thereof
EP1638508A4 (en) Shunt for the treatment of glaucoma